UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae

Antimicrobial Agents and Chemotherapy, 2001-10, Vol.45 (10), p.2807-2812

2001

Volltextzugriff (PDF)

Molecular Basis for the Preferential Cleft Recognition by Dromedary Heavy-Chain Antibodies

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (12), p.4586-4591

2006

Volltextzugriff (PDF)

Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs

The Journal of biological chemistry, 2001-03, Vol.276 (10), p.7346-7350

2001

Volltextzugriff (PDF)

Antibody repertoire development in camelids

Developmental and comparative immunology, 2006, Vol.30 (1), p.187-198

2006

Volltextzugriff (PDF)

Identification of a Universal VHH Framework to Graft Non-canonical Antigen-binding Loops of Camel Single-domain Antibodies

Journal of molecular biology, 2005-09, Vol.352 (3), p.597-607

2005

Volltextzugriff (PDF)

Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis

Journal of medicinal chemistry, 2021-01, Vol.64 (1), p.343-353

2021

Volltextzugriff (PDF)

Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific Antigen

The Journal of biological chemistry, 2004-12, Vol.279 (50), p.51965-51972

2004

Volltextzugriff (PDF)

Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction

The European respiratory journal, 2022-07, Vol.60 (1), p.2101581

2022

Volltextzugriff (PDF)

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Journal of cystic fibrosis, 2019-09, Vol.18 (5), p.700-707

2019

Volltextzugriff (PDF)

Correction to “Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis”

Journal of medicinal chemistry, 2021-09, Vol.64 (18), p.13933-13933

2021

Volltextzugriff (PDF)

Engineering Camel Single-Domain Antibodies and Immobilization Chemistry for Human Prostate-Specific Antigen Sensing

Analytical chemistry (Washington), 2005-12, Vol.77 (23), p.7547-7555

2005

Volltextzugriff (PDF)

Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase

Protein science, 2009-03, Vol.18 (3), p.619-628

2009

Volltextzugriff (PDF)

A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase III

Antimicrobial agents and chemotherapy, 2013, Vol.57 (10), p.4971-4981

2013

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae

Molecular Basis for the Preferential Cleft Recognition by Dromedary Heavy-Chain Antibodies

Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs

Discovery of N‑(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro‑4H‑thieno[2,3‑c]pyran-2-yl)‑lH‑pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent

Antibody repertoire development in camelids

Identification of a Universal VHH Framework to Graft Non-canonical Antigen-binding Loops of Camel Single-domain Antibodies

Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis

Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific Antigen

Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Correction to “Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis”

Engineering Camel Single-Domain Antibodies and Immobilization Chemistry for Human Prostate-Specific Antigen Sensing

Discovery of N -(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4 H -thieno[2,3- c ]pyran-2-yl)-l H -pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent

Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase

A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase III

Suchergebnisse filtern